Morgan Stanley toned down its emphasis on diversity in its latest annual report published on Friday, signaling a recalibration as businesses adapt to a changing reality under President Donald Trump's ...
US defense contractors are on shaky ground just a month into the new administration — taking a backseat to European peers — ...
Market activity has been somewhat "subdued," and USTs yields have been "relatively well-behaved," though the 10- to 30-year ...
The general mood among these heavyweight investors is divided, with 57% leaning bullish and 21% bearish. Among these notable ...
An index of sentiment among French industry rose to 97 in February from 96 a month earlier, statistics agency Insee said Friday. That was a little better than economists had expected and suggests ...
RBC Capital analyst Charles Weston maintained a Buy rating on Sartorius Stedim Biotech (0RG8 – Research Report) today and set a price target of ...
Barclays hit the dollar market in force with two trades in successive days this week to raise a total of $6.5bn.
Non-profit healthcare provider HCA Inc printed the biggest trade of the week as it raised $5.25bn in a six-part offering to repay its borrowing facility. Wells Fargo, Barclays, Bank of America, Citi, ...
Stocks were mostly lower on Thursday after a disappointing business forecast from retail giant Walmart (WMT). The S&P 500, ...
In terms of liquidity and interest, the mean open interest for CRISPR Therapeutics options trades today is 628.14 with a total volume of 1,152.00.
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...
RBC Capital analyst Chris Dendrinos maintained a Hold rating on SolarEdge Technologies (SEDG – Research Report) yesterday and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results